A Study to Learn How Different Amounts of the Study Medicine Called PF-07985631 Are Tolerated and Act in the Body of Healthy Adults

计划入组 92 人 · 首次发布于 2025 年 5 月 29 日

A Study to Learn How Different Amounts of the Study Medicine Called PF-07985631 Are Tolerated and Act in the Body in Healthy Adults

计划入组 9 人 · 首次发布于 2025 年 11 月 19 日

Intrapartum Ultrasonography in Evaluation of the Progress of Labor

计划入组 300 人 · 首次发布于 2023 年 4 月 21 日

PF-05221304 + PF-06865571

PF-610355/PF-258210

PF-562271

PF PRISM C.V.

Netherlands

PF Consumer Healthcare Canada ULC

Canada

PF Consumer Healthcare B.V. (Puerto Rico Operations) LLC

United States

Pfizer Advances Two Phase 1 Trials Targeting Kidney Disease and Liver Cancer

Pfizer Discontinues Mesothelin-Targeting ADC PF-08052666 Amid Strategic Pipeline Restructuring

First-in-Human Study of PF-06647020 (Cofetuzumab) in Patients with Advanced Solid Tumors